Target intelligence / Profile preview

T cell receptor beta variable 27 (TRBV27)

Target
TRBV27
Molecular classification
Receptor, T cell receptor (TCR) family, Cell surface receptor, Immunoglobulin superfamily
01

Overview

T cell receptor beta variable 27 is a variable region segment of the beta chain of the T cell receptor (TCR), a heterodimeric surface receptor critical for antigen-specific immune responses of T lymphocytes. TRBV27 contributes to the antigen recognition domain of TCRs, enabling T cells to recognize peptide–MHC (major histocompatibility complex) complexes presented by antigen-presenting cells. Recognition of these complexes is essential to initiate adaptive immune responses, including the activation and differentiation of T cells. Upon antigen binding, the TCR complex signals through associated CD3 molecules, triggering phosphorylation events and the assembly of intracellular signaling complexes. This results in the activation of several pathways (including MAP kinase and NF-κB), promoting gene expression changes required for T cell activation, proliferation, and differentiation. Diversity in TRBV usage underlies T cell repertoire variability, which is crucial for effective immunity and tolerance[1][2][8].

Other names
TCRBV14S1TCRBV27S1V_segment translation productTRBV27
02

Biological functions

Antigen recognitionImmune responseSignal transductionT cell activation
03

Disease associations

CancerInfectionInflammationAutoimmune disease
04

Safety considerations

Immune-related adverse events (if manipulated therapeutically)Risk of autoimmunity (with off-target T cell activation)

Beyond the preview

Go deeper on T cell receptor beta variable 27 (TRBV27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 27 (TRBV27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call